COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe …

P Ghasemiyeh, S Mohammadi-Samani - Heart & Lung, 2020 - Elsevier
Abstract The new coronavirus (COVID-19) was first detected in Wuhan city of China in
December 2019. Most patients infected with COVID-19 had clinical presentations of dry …

[HTML][HTML] COVID-19: Clinical aspects and therapeutics responses

S Khan, A Ali, H Shi, R Siddique, G Nabi, J Hu… - Saudi Pharmaceutical …, 2020 - Elsevier
COVID-19 has created havoc in the world by causing thousands of demises in a short period
of time. Up till now, several attempts have been made for potential therapeutics against …

Covid-19 and drug therapy, what we learned

A Provenzani, P Polidori - International journal of clinical pharmacy, 2020 - Springer
COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-
2, was observed for the first time in China and then spread worldwide becoming pandemic …

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …

Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

[PDF][PDF] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - cureus.com
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

COVID-19 drug treatment in China

L Fan, S Jiang, X Yang, Z Wang, C Yang - Current Pharmacology Reports, 2020 - Springer
Abstract Purpose of Review An unprecedented outbreak of the novel coronavirus in China
(COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a …

Drug treatment of COVID-19 infection

G Lui, G Guaraldi - Current Opinion in Pulmonary Medicine, 2023 - journals.lww.com
Drug treatment of COVID-19 infection : Current Opinion in Pulmonary Medicine Drug treatment
of COVID-19 infection : Current Opinion in Pulmonary Medicine Log in or Register Subscribe to …